Behavioral and neurophysiological effects of an intensified robot-assisted therapy in subacute stroke: a case control study.
Aida Sehle, Jana Stuerner, Thomas Hassa and 3 others
PMID 33430912WHAT IT FOUND
Adding intensive robot-assisted arm training to standard inpatient rehabilitation did not improve upper limb function more than standard care alone in subacute stroke patients.
Both groups improved significantly, but the extra training offered no clinical advantage over the conventional therapy they already received.
Key findings
01The primary outcome showed no significant difference in upper limb function between the group receiving additional robot training and the control group at any time point.
02Both groups improved significantly in Fugl-Meyer Assessment scores, with the intervention group improving by 10.6 points and the control group by 7.3 points from baseline to post-test.
03Neurophysiological measures showed increased motor excitability in the intervention group, which correlated with clinical improvement, but this did not translate to superior functional outcomes compared to controls.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study had a small sample size (n=30), limiting the power to detect subtle differences. The intervention period was short (three weeks), which may have been insufficient to observe behavioral benefits, especially in severely affected patients. Both groups received standard inpatient rehabilitation, which included low-dose robot-assisted therapy, potentially masking the effect of the additional high-dose intervention. Spontaneous recovery in the subacute phase likely contributed to improvements in both groups, making it difficult to attribute gains solely to the intervention. Patients with severe apraxia or neglect were excluded, limiting generalizability to the full spectrum of post-stroke upper limb deficits.
Declared interests
The study was supported by non-U.S. government funding. The authors declared no conflicts of interest related to the device manufacturer (Hocoma AG).
The easy way to misread this
Do not conclude that robot-assisted therapy is ineffective for stroke rehabilitation. This study shows that *adding* intensive robot training to an already comprehensive inpatient program did not provide *extra* benefit over the standard care these patients were already receiving, which included some robot therapy. The null result may reflect the high baseline level of standard care rather than the ineffectiveness of the modality itself.